Overall, these results suggest that several MAPK and PI3K/AKT pathway components and FAK, among others, may participate in adaptive response mechanisms promoting resistance to rapamycin in HNSCC cells. The gene discussed is PTK2; the disease is head and neck squamous cell carcinoma.